Lower-cost transactional solutions with strategic resourcing and innovative technologies.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Designed to enhance patient engagement and support patient recruitment and retention.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
Understand and successfully address the complexities of adaptive trial design.
Access the white paper and maximise benefits in observational studies and clinical trials.
ICON sponsored research outlines partnership strategies to optimise clinical development.
5 AprilDevelop a comprehensive health economic and epidemiologic evidence strategy
26 AprilAddress the challenges of Type II Diabetes global clinical trials
18 MayBringing together industry leaders from across healthcare and life sciences
From a small team of 5 people in 1990, ICON now employs over 12,600 professionals in 37 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.
Full year 2016: net business wins of $1.9 billion; Net revenue $1,666
million; EPS $4.77
Net business wins of $510 million; Net revenue $420 million; EPS $1.19